It was noted that reduction of AKR1C1 by siRNA in human colon cancer enhances the sensitivity toward cisplatin, whereas overexpression of AKR1C1 is highly associated with the cisplatin resistance [26]. This evidence concerns the gene AKR1C1 and colonic neoplasm.